Percheron Therapeutics(DE:AWY0)
€0.03+0.00 (+3.23%)
DE:AWY0
Percheron Therapeutics financials statements
€0.03
At close:+0.00 (+3.23%)
Percheron Therapeutics (AWY0) Income Statement
0 Followers
Percheron Therapeutics Income Statement
Last quarter (Q4 2026), Percheron Therapeutics's total revenue was AU$0.00. In Q4, Percheron Therapeutics's net income was AU$-1.69M. See Percheron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | |
| AU$ -219.56K | AU$ -67.98K | AU$ -79.42K | AU$ -95.20K | AU$ -89.22K | |
| AU$ 5.40M | AU$ 16.64M | AU$ 14.80M | AU$ 13.25M | AU$ 7.52M | |
| Depreciation and Amortization | AU$ 219.56K | AU$ 67.98K | AU$ 79.42K | AU$ 95.20K | AU$ 89.22K |
| AU$ -5.40M | AU$ -16.27M | AU$ -11.84M | AU$ -13.25M | AU$ -7.52M | |
| AU$ -5.62M | AU$ -16.71M | AU$ -14.88M | AU$ -13.34M | AU$ -7.61M | |
| AU$ 131.91K | AU$ 356.16K | AU$ 608.89K | AU$ 385.30K | AU$ 21.52K | |
| AU$ -5.49M | AU$ -16.35M | AU$ -14.27M | AU$ -12.96M | AU$ -7.59M | |
| AU$ -4.79M | AU$ -14.92M | AU$ -11.92M | AU$ -11.38M | AU$ -5.81M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.00 | AU$ -0.01 | AU$ -0.02 | AU$ -0.02 | AU$ -0.01 |
| Diluted EPS | AU$ -0.00 | AU$ -0.01 | AU$ -0.02 | AU$ -0.02 | AU$ -0.01 |
| Weighted Average Shares Outstanding | 1.17B | 1.02B | 669.03M | 669.03M | 634.29M |
| Weighted Average Shares Outstanding (Diluted) | 1.17B | 1.02B | 669.03M | 669.03M | 634.29M |
Currency in AUD
